Lipoprotein(a) accelerates atherosclerosis in uremic mice

Pharmacology, Toxicology and Pharmaceutical Science

• Mouse 100%
• Lipoprotein A 100%
• Atherosclerosis 100%
• Apolipoprotein 64%
• Uremia 35%
• Phospholipid 28%
• Apolipoprotein B100 28%
• Transgenic Mouse 21%
• Wild Type Mouse 14%
• Low Density Lipoprotein Cholesterol 7%
• Cardiovascular Disease 7%
• Lipoprotein 7%
• Disulfide 7%
• Aortic Atherosclerosis 7%

Medicine and Dentistry

• Atherosclerosis 100%
• Lipoprotein 100%
• Apolipoprotein 60%
• Uremia 33%
• Phospholipid 26%
• Apolipoprotein B100 26%
• Transgenic Mouse 20%
• Low Density Lipoprotein Cholesterol 6%
• Cardiovascular Disease 6%
• Nephrectomy 6%
• Disulfide 6%
• Lipid Diet 6%
• Aortic Root 6%
• Aortic Atherosclerosis 6%

Keyphrases

• Lipoproteins 100%
• Apolipoprotein(a) 60%
• Uremia 33%
• Apolipoprotein B-100 26%
• Oxidized Phospholipids 26%
• Transgenic Mice 20%
• Transgenic 20%
• Wild Mice 13%
• Cardiovascular Risk 6%
• Plasma Lipoproteins 6%
• Atherosclerotic Plaque 6%
• 5/6 Nephrectomy 6%
• Uremic Patients 6%
• Human Lipoproteins 6%
• LDL Cholesterol 6%
• Atherogenicity 6%
• Plaque Area 6%
• Aortic Root 6%
• Disulfide 6%
• Large Artery Atherosclerosis 6%
• High-fat Diet 6%
• Transgenic Expression 6%